3S Bio raises a healthy $711m via HK IPO
The mainland Chinese biotech firm generated strong demand, with the retail tranche of the offering on the Hong Kong bourse 200-times oversubscribed.
June 07, 2015
- News
-
Investment Lifecycle
Deals & Trends
Rainmakers
Regions
- Research
-
- Awards
-
- Events
- Photo Gallery
